Scott Terrillion, Sec'y, Chief Compliance & G.C at Cara Therapeutics, Inc. (CARA), sold 3,980 shares at $17.05 ($68K) on 2019-12-04, disclosed to the SEC on 2019-12-04.
Open-market sale of $68k CARA by Sec'y, Chief Compliance & G.C. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CARA | SELL | 2024-03-04 | $3K | — | Filing → |
| CARA | SELL | 2024-02-12 | $4K | — | Filing → |
| CARA | SELL | 2023-06-27 | $9K | — | Filing → |